The 340B drug discount program is not effectively fulfilling its intended role of reducing medication costs and delivering comprehensive services for vulnerable patients due to its complexity, poor oversight, and misaligned incentives. The healthcare system’s rapid evolution has exacerbated these problems. The system’s stakeholders, including healthcare providers and pharmaceutical manufacturers, must unite in modernizing this 30-year-old initiative. High-tech tools and data analytics can streamline processes, provide clarity, and foster collaboration in handling the program’s complexities. Implementing reforms would help fulfill the program’s mission to provide affordable medication and comprehensive care for patients.
Inside Healthcare’s Hottest New AI Category: Agentic AI
Artificial Intelligence (AI) agents are receiving increasing attention in healthcare as they provide solutions to cost containment and improve patient outcomes. AI agents can help
